{"description":"Documents matching 'security there domestic emergency significant'","count":8171,"total_pages":50,"next_page_url":"https://www.federalregister.gov/api/v1/documents?conditions%5Bterm%5D=security+there+domestic+emergency+significant&format=json&page=2","results":[{"title":"Authorization of Emergency Use for Two Animal Drugs for the Prevention and Treatment of New World Screwworm; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or the Agency) is announcing the issuance of two Emergency Use Authorizations (EUA) (Authorization) under the Federal Food, Drug, and Cosmetic Act (FD&C Act) for new animal products. FDA has issued one EUA for an animal product as requested by Health and Hygiene (Pty) Ltd. for the prevention and treatment of infestations caused by New World screwworm (Cochliomyia hominivorax) (NWS) larvae (myiasis) in cattle, horses, minor species of hoof stock, raptors and other wild birds, pet birds, and captive wild, exotic, and zoo mammals. FDA has issued one EUA for an animal product as requested by Elanco US Inc. for the prevention and treatment of infestations caused by NWS larvae (myiasis) in cattle, swine, goats, sheep, horses, donkeys, domestic hybrid equids, and captive wild, exotic, and zoo mammals. The Authorizations contain, among other things, conditions on the emergency use of the authorized products. The Authorizations follow the August 18, 2025, determination by the Secretary of Health and Human Services (HHS) that there is a significant potential for a public health emergency that has a significant potential to affect national security or the health and security of U.S. citizens living abroad and that involves NWS. On the basis of such determination, the Secretary of HHS declared on August 18, 2025, that circumstances exist justifying the authorization of emergency use of animal drugs to treat or prevent NWS myiasis in animals. The Authorizations, which include an explanation of the reasons for issuance, are reprinted in this document.","document_number":"2026-12245","html_url":"https://www.federalregister.gov/documents/2026/06/18/2026-12245/authorization-of-emergency-use-for-two-animal-drugs-for-the-prevention-and-treatment-of-new-world","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-18/pdf/2026-12245.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-12245.pdf?1781700311","publication_date":"2026-06-18","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"authorization based on one of the following grounds: (A) a determination by the Secretary of Homeland Security that there is a domestic emergency, or a significant potential for a domestic emergency, involving a heightened risk of attack with a biological, chemical, radiological, or nuclear agent or agents (“CBRN”); (B) a determination by the Secretary of Defense that there is a military emergency, or a significant potential for a military emergency, involving a heightened risk to U.S. military forces, including personnel operating under the authority"},{"title":"Termination of Declaration Authorizing Emergency Use of Drug and Biological Products During the COVID-19 Pandemic","type":"Notice","abstract":"The Secretary of Health and Human Services is issuing this notice pursuant to section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C) Act. On February 4, 2020, as amended on March 15, 2023, the HHS Secretary determined that there is a public health emergency, or significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of United States (U.S.) citizens living abroad, and that involves the virus (later referred to as SARS-CoV-2) that causes COVID- 19. Based on this determination, on March 27, 2020, the HHS Secretary declared that circumstances exist justifying the authorization of emergency use of drugs and biological products during the COVID-19 pandemic. On June 29, 2026, the HHS Secretary determined that circumstances no longer exist justifying the authorization of emergency use of drugs and biological products during the COVID-19 pandemic. Based on this determination, the HHS Secretary is terminating this declaration, effective on June 29, 2027.","document_number":"2026-13374","html_url":"https://www.federalregister.gov/documents/2026/07/02/2026-13374/termination-of-declaration-authorizing-emergency-use-of-drug-and-biological-products-during-the","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-07-02/pdf/2026-13374.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-13374.pdf?1782832508","publication_date":"2026-07-02","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"}],"excerpts":"potential for a domestic emergency, involving a heightened risk of attack with a biological, chemical, radiological, or nuclear (“CBRN”) agent or agents; (2) the identification of a material threat by the Secretary of Homeland Security pursuant to section 319F-2 of the Public Health Service \n \n (PHS) Act \n 1 \n \n sufficient to affect national security or the health and security of U.S. citizens living abroad; (3) a determination by the Secretary of Defense that there is a military emergency, or a significant potential for a military emergency, involving"},{"title":"Termination of Three Declarations Authorizing Emergency Use of Medical Devices During the COVID-19 Pandemic","type":"Notice","abstract":"The Secretary of Health and Human Services (HHS) is issuing this notice pursuant to section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C) Act. On February 4, 2020, as amended on March 15, 2023, HHS determined that there is a public health emergency, or significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad, and that involves the virus (later referred to as SARS-CoV-2) that causes COVID-19. On the basis of this determination, the HHS Secretary declared that circumstances exist justifying the authorization of emergency use of (1) in vitro diagnostics for detection and/or diagnosis of SARS-CoV-2 (February 4, 2020); (2) personal respiratory protective devices during the COVID-19 outbreak (March 2, 2020); and (3) medical devices, including alternative products used as medical devices (March 24, 2020). On June 29, 2026, the HHS Secretary determined that circumstances no longer exist justifying the authorization of emergency use of these medical devices. On the basis of this determination, the HHS Secretary is terminating these declarations (\"EUA declarations\"), effective on December 26, 2026.","document_number":"2026-13373","html_url":"https://www.federalregister.gov/documents/2026/07/02/2026-13373/termination-of-three-declarations-authorizing-emergency-use-of-medical-devices-during-the-covid-19","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-07-02/pdf/2026-13373.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-13373.pdf?1782832508","publication_date":"2026-07-02","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"}],"excerpts":"amended on March 15, 2023, HHS determined that there is a public health emergency, or significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad, and that involves the virus (later referred to as SARS-CoV-2) that causes COVID-19. On the basis of this determination, the HHS Secretary declared that circumstances exist justifying the authorization of emergency use of (1) in vitro diagnostics for detection and/or diagnosis of SARS-CoV-2"},{"title":"Authorization of Emergency Use for Two Animal Drugs for the Treatment of New World Screwworm; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or the Agency) is announcing the issuance of two Emergency Use Authorizations (EUA) (Authorization) under the Federal Food, Drug, and Cosmetic Act (FD&C Act) for new animal drug products. FDA has issued one EUA for a new animal drug product as requested by Elanco US Inc. for the treatment of infestations caused by New World screwworm (Cochliomyia hominivorax) (NWS) larvae (myiasis) in dogs and puppies and one EUA for a new animal drug product as requested by Elanco US Inc. for the treatment of infestations caused by NWS larvae (myiasis) in cats and kittens. The Authorizations contain, among other things, conditions on the emergency use of the authorized products. The Authorizations follow the August 18, 2025, determination by the Secretary of Health and Human Services (HHS) that there is a public health emergency, or a significant potential for a public health emergency, that affects or has a significant potential to affect national security or the health and security of U.S. citizens living abroad and that involves NWS. On the basis of such determination, the Secretary of HHS declared on August 18, 2025, that circumstances exist justifying the authorization of emergency use of animal drugs to treat or prevent NWS myiasis in animals. The Authorizations, which include an explanation of the reasons for issuance, are reprinted in this document.","document_number":"2025-23914","html_url":"https://www.federalregister.gov/documents/2025/12/29/2025-23914/authorization-of-emergency-use-for-two-animal-drugs-for-the-treatment-of-new-world-screwworm","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-12-29/pdf/2025-23914.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-23914.pdf?1766497525","publication_date":"2025-12-29","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"the authorization based on one of the following grounds: (A) a determination by the Secretary of Homeland Security that there is a domestic emergency, or a significant potential for a domestic emergency, involving a heightened risk of attack with a biological, chemical, radiological, or nuclear agent or agents; (B) a determination by the Secretary of Defense that there is a military emergency, or a significant potential for a military emergency, involving a heightened risk to U.S. military forces, including personnel operating under the authority"},{"title":"Declaration of Emergency Pursuant to the Federal Food, Drug, and Cosmetic Act for New World Screwworm","type":"Notice","abstract":"The Secretary of Health and Human Services (HHS) is issuing this notice pursuant to the Federal Food, Drug, and Cosmetic (FD&C) Act. On August 18, 2025, the Secretary determined, pursuant to his authority under the FD&C Act, that there is a significant potential for a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad and that involves New World Screwworm (Cochliomyia hominivorax) (NWS).","document_number":"2025-15918","html_url":"https://www.federalregister.gov/documents/2025/08/20/2025-15918/declaration-of-emergency-pursuant-to-the-federal-food-drug-and-cosmetic-act-for-new-world-screwworm","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-08-20/pdf/2025-15918.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-15918.pdf?1755607553","publication_date":"2025-08-20","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Office of the Secretary"}],"excerpts":"section 564(b): (1) A determination by the Secretary of Homeland Security that there is a domestic emergency, or a significant potential for a domestic emergency, involving a heightened risk of attack with a, chemical, biological, radiological, or nuclear (“CBRN”) agent or agents; (2) the identification of a material threat by the Secretary of the Homeland Security pursuant to section 319F-2 of the Public Health Service (PHS) Act sufficient to affect national security or the health and security of United States citizens living abroad; (3) a determination"},{"title":"Authorization of Emergency Use for Four Animal Drugs for the Treatment of New World Screwworm; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or the Agency) is announcing the issuance of four Emergency Use Authorizations (EUA) (Authorization) under the Federal Food, Drug, and Cosmetic Act (FD&C Act) for new animal products. FDA has issued three EUAs for animal products as requested by Boehringer Ingelheim Animal Health USA, Inc. (Boehringer) for the prevention of infestations caused by New World screwworm (Cochliomyia hominivorax) (NWS) larvae (myiasis) in certain cattle, and for the treatment of such infestations in dogs, and cats. FDA has issued one EUA for an animal product as requested by Health and Hygiene (Pty) Ltd. for the prevention and treatment of infestations caused by NWS larvae (myiasis) in cattle, horses, minor species of hoof stock (e.g., sheep, goats, deer), raptors and other wild birds, pet birds, and captive wild, exotic, and zoo mammals. The Authorizations contain, among other things, conditions on the emergency use of the authorized products. The Authorizations follow the August 18, 2025, determination by the Secretary of Health and Human Services (HHS) that there is a significant potential for a public health emergency that has a significant potential to affect national security or the health and security of U.S. citizens living abroad and that involves NWS. On the basis of such determination, the Secretary of HHS declared on August 18, 2025, that circumstances exist justifying the authorization of emergency use of animal drugs to treat or prevent NWS myiasis in animals. The Authorizations, which include an explanation of the reasons for issuance, are reprinted in this document.","document_number":"2026-07509","html_url":"https://www.federalregister.gov/documents/2026/04/17/2026-07509/authorization-of-emergency-use-for-four-animal-drugs-for-the-treatment-of-new-world-screwworm","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-17/pdf/2026-07509.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-07509.pdf?1776343516","publication_date":"2026-04-17","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"authorization based on one of the following grounds: (A) a determination by the Secretary of Homeland Security that there is a domestic emergency, or a significant potential for a domestic emergency, involving a heightened risk of attack with a biological, chemical, radiological, or nuclear agent or agents (“CBRN”); (B) a determination by the Secretary of Defense that there is a military emergency, or a significant potential for a military emergency, involving a heightened risk to U.S. military forces, including personnel operating under the authority"},{"title":"Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or the Agency) is announcing the issuance of Emergency Use Authorizations (EUA) (the Authorizations) for certain medical devices related to Coronavirus Disease 2019 (COVID-19). FDA has issued the Authorizations listed in this document under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Under the FD&C Act, FDA is required to publish in the Federal Register a notice of each authorization, and each termination or revocation of an authorization, and an explanation of the reasons for the action. These Authorizations contain, among other things, conditions on the emergency use of the authorized products. The Authorizations follow the February 4, 2020, determination by the Secretary of Health and Human Services (HHS), as amended on March 15, 2023, that there is a public health emergency, or a significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad and that involves the virus that causes COVID-19, and the subsequent declarations on February 4, 2020, March 2, 2020, and March 24, 2020, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19, personal respiratory protective devices, and medical devices, including alternative products used as medical devices, respectively, subject to the terms of any authorization issued under the FD&C Act. These Authorizations, which include an explanation of the reasons for issuance, are listed in this document, and can be accessed on FDA's website from the links indicated.","document_number":"2026-01069","html_url":"https://www.federalregister.gov/documents/2026/01/21/2026-01069/authorization-of-emergency-use-of-certain-medical-devices-during-covid-19-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-01-21/pdf/2026-01069.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-01069.pdf?1768916716","publication_date":"2026-01-21","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"for the action. These Authorizations contain, among other things, conditions on the emergency use of the authorized products. The Authorizations follow the February 4, 2020, determination by the Secretary of Health and Human Services (HHS), as amended on March 15, 2023, that there is a public health emergency, or a significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad and that involves the virus that causes COVID-19, and"},{"title":"Hazardous Materials: Reducing Undue Paperwork Burdens to Domestic Carriers","type":"Proposed Rule","abstract":"This NPRM proposes to revise the Hazardous Materials Regulations (HMR) to provide domestic carriers the option to maintain electronic copies of emergency response information rather than requiring a hard copy printed on paper.","document_number":"2025-12066","html_url":"https://www.federalregister.gov/documents/2025/07/01/2025-12066/hazardous-materials-reducing-undue-paperwork-burdens-to-domestic-carriers","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-01/pdf/2025-12066.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-12066.pdf?1751055311","publication_date":"2025-07-01","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Pipeline and Hazardous Materials Safety Administration","name":"Pipeline and Hazardous Materials Safety Administration","id":408,"url":"https://www.federalregister.gov/agencies/pipeline-and-hazardous-materials-safety-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/408","parent_id":492,"slug":"pipeline-and-hazardous-materials-safety-administration"}],"excerpts":"this proposed rule is not a “significant energy action” under E.O. 13211 (“Actions Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use”),\n 7 \n \n which requires Federal agencies to prepare a Statement of Energy Effects for any “significant energy action.” Because this proposed rule is not a significant action under E.O. 12866, it will not have a significant adverse effect on supply, distribution, or energy use; and OIRA has therefore not designated this proposed rule as a significant energy action.\n \n \n \n 7 \n 66"},{"title":"Regulatory Guide: Emergency Response Planning and Preparedness for Nuclear Power Reactors","type":"Rule","abstract":"The U.S. Nuclear Regulatory Commission (NRC) is issuing Revision 7 to Regulatory Guide (RG) RG-1.101, \"Emergency Response Planning and Preparedness for Nuclear Power Reactors.\" This revision updates the list of NRC-developed and NRC-endorsed guidance documents acceptable to meet the regulatory requirements for emergency response planning and preparedness. This revision also provides generic guidance for maintaining regulatory compliance for alert and notification systems (ANS) when making significant design changes, as well as provides guidance on a method to justify a 24-month frequency for emergency plan reviews.","document_number":"2025-18633","html_url":"https://www.federalregister.gov/documents/2025/09/25/2025-18633/regulatory-guide-emergency-response-planning-and-preparedness-for-nuclear-power-reactors","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-09-25/pdf/2025-18633.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-18633.pdf?1758717922","publication_date":"2025-09-25","agencies":[{"raw_name":"NUCLEAR REGULATORY COMMISSION","name":"Nuclear Regulatory Commission","id":383,"url":"https://www.federalregister.gov/agencies/nuclear-regulatory-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/383","parent_id":null,"slug":"nuclear-regulatory-commission"}],"excerpts":"for complying with the NRC's regulations for emergency response plans and preparedness at nuclear power reactors in section 50.47 of title 10 of the \n Code of Federal Regulations \n (10 CFR), “Emergency plans,” and appendix E, “Emergency Planning and Preparedness for Production and Utilization Facilities,” to 10 CFR part 50, “Domestic Licensing of Production and Utilization Facilities.” This revision endorses Nuclear Energy Institute (NEI) white paper, “Enabling a Remote Response by Members of an Emergency Response Organization,” Revision 1, issued"},{"title":"Cancellation and Replacement of Emergency Order Establishing Operating Limitations on the Use of Navigable Airspace","type":"Notice","abstract":"This Order cancels and replaces the November 7, 2025, Emergency Order Establishing Operating Limitations on the Use of Navigable Airspace (November 7 Emergency Order) reducing and temporarily prohibiting certain operations in the navigable airspace to ensure the safety of aircraft and the efficiency of the National Airspace System (NAS). This Order modifies the requirement of the November 7 Emergency Order to reduce operations at certain airports by 10 percent, by reducing the required reduction in operations to 6 percent. Accordingly, to maintain the highest standards of safety in the NAS, certain air carriers will be required to reduce their total daily scheduled domestic operations between 6:00 a.m. and 10:00 p.m. local at certain airports by 6 percent, subject to the provisions set forth in this Order. This Order retains other restrictions in NAS operations and reductions in available Air Traffic Organization services contained in the November 7 Emergency Order.","document_number":"2025-19986","html_url":"https://www.federalregister.gov/documents/2025/11/17/2025-19986/cancellation-and-replacement-of-emergency-order-establishing-operating-limitations-on-the-use-of","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-11-17/pdf/2025-19986.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-19986.pdf?1763068513","publication_date":"2025-11-17","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Federal Aviation Administration","name":"Federal Aviation Administration","id":159,"url":"https://www.federalregister.gov/agencies/federal-aviation-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/159","parent_id":492,"slug":"federal-aviation-administration"}],"excerpts":"Cancellation and replacement of Emergency Order Establishing Operating Limitations on the Use of Navigable Airspace. \n \n \n SUMMARY: \n This Order cancels and replaces the November 7, 2025, Emergency Order Establishing Operating Limitations on the Use of Navigable Airspace (November 7 Emergency Order) reducing and temporarily prohibiting certain operations in the navigable airspace to ensure the safety of aircraft and the efficiency of the National Airspace System (NAS). This Order modifies the requirement of the November 7 Emergency Order to reduce operations"},{"title":"Medicare Program; Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals","type":"Proposed Rule","abstract":"This advance notice of proposed rulemaking solicits public comment on potential options we may consider for Medicare participating hospitals to help foster a more resilient supply chain for American- made personal protective equipment and essential medicines to secure our nation's health and safety and to reflect the additional resource costs incurred when procuring these domestically manufactured items. We seek input on a possible new \"Secure American Medical Supplies\" friendly designation that could be earned by hospitals that demonstrate their commitment to domestic procurement. In addition, we seek input on potential ways such a designation could facilitate the creation of new, streamlined payment policies to support hospitals in their efforts. We are also seeking input on a potential new structural quality measure as part of the Hospital Inpatient Quality Reporting (IQR) Program that could promote hospital commitments to invest in domestic procurement to secure our nation's health and safety.","document_number":"2026-01730","html_url":"https://www.federalregister.gov/documents/2026/01/29/2026-01730/medicare-program-ensuring-safety-through-domestic-security-with-made-in-america-personal-protective","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-01-29/pdf/2026-01730.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-01730.pdf?1769465709","publication_date":"2026-01-29","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"marginal costs for hospitals for procuring domestically made PPE and essential medicines. For example, an ASPR review of publicly available individual and wholesale prices for both domestic and non-domestic nitrile gloves on manufacturer websites shows that the price of domestically manufactured nitrile gloves is approximately 1.5 to 3 times that of non-domestically manufactured nitrile gloves. A similar ASPR review of the publicly available prices of API from domestic and non-domestic sources reveals that domestic API are, on average, approximately 12"},{"title":"Cancellation of Emergency Order Establishing Operating Limitations on the Use of Navigable Airspace","type":"Notice","abstract":"This Order cancels the November 12, 2025, \"Emergency Order Establishing Operating Limitations on the Use of Navigable Airspace,\" as amended by the November 14, 2025, Addendum, (November 12 Emergency Order) reducing and temporarily prohibiting certain operations in the navigable airspace to ensure the safety of aircraft and the efficiency of the National Airspace System (NAS). This Order cancels all requirements of the November 12 Emergency Order including to reduce operations at certain airports by 3 percent, and restores normal operating levels on the effective date of this Order. This Order also cancels the prohibition on operations by general aviation 14 CFR part 91 aircraft, non-scheduled 14 CFR part 135 aircraft, and 14 CFR part 380 public charter aircraft at certain airports, and the prohibition on commercial space launches and reentries during peak hours, and resumes normal air traffic control (ATC) services limited by the November 12 Emergency Order.","document_number":"2025-20308","html_url":"https://www.federalregister.gov/documents/2025/11/19/2025-20308/cancellation-of-emergency-order-establishing-operating-limitations-on-the-use-of-navigable-airspace","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-11-19/pdf/2025-20308.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-20308.pdf?1763414113","publication_date":"2025-11-19","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Federal Aviation Administration","name":"Federal Aviation Administration","id":159,"url":"https://www.federalregister.gov/agencies/federal-aviation-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/159","parent_id":492,"slug":"federal-aviation-administration"}],"excerpts":"Airports”) of the November 12 Emergency Order. This data indicated a correlation between ATO staffing and stress on the NAS, prompting the FAA to issue an order entitled “Emergency Order Establishing Operating Limitations on the Use of Navigable Airspace” on November 7, 2025, to mitigate safety concerns and to address ATC stressors by requiring certain air carriers to reduce their total daily scheduled domestic operations between 6:00 a.m. and 10:00 p.m. local. The order required gradually increasing reductions in domestic operations at High Impact"},{"title":"Tanker Security Program","type":"Rule","abstract":"This final rule implements the Tanker Security Program (TSP) and makes certain changes to the TSP interim final rule (IFR) published in the Federal Register on December 7, 2022, in response to public comments received on the IFR, feedback from stakeholders, and MARAD's own experience during initial program administration. The Secretary of Transportation is authorized to establish TSP, comprised of a fleet of active, commercially viable, militarily useful, privately owned product tank vessels of the United States. The TSP Fleet is intended to meet national defense and other security requirements and maintain a United States presence in international commercial shipping. TSP supports the United States maritime industries and workforce to promote national security and economic resilience.","document_number":"2026-12547","html_url":"https://www.federalregister.gov/documents/2026/06/23/2026-12547/tanker-security-program","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-23/pdf/2026-12547.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-12547.pdf?1782132312","publication_date":"2026-06-23","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Maritime Administration","name":"Maritime Administration","id":282,"url":"https://www.federalregister.gov/agencies/maritime-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/282","parent_id":492,"slug":"maritime-administration"}],"excerpts":"sudden crisis, armed conflict, or national emergency requiring the use of these vessels by the Government to meet urgent needs.\n \n \n MARAD is clarifying § 294.23(d) to promote the sustainability of the Tanker Security Fleet in the event of a national security event. Under 46 U.S.C. 53407 and 46 CFR 294.23(d), all vessels operating in TSP must enter into a Voluntary Tanker Agreement (VTA), in which they commit to make their TSP vessel available to fulfill DOW requirements in times of war or national emergency. MARAD has clarified that a vessel activated"},{"title":"Declaration of Emergency Pursuant to the Federal Food, Drug and Cosmetic Act","type":"Notice","abstract":"The Secretary of Health and Human Services (HHS) is issuing this notice pursuant to the Federal Food, Drug, and Cosmetic (FD&C) Act. On July 18, 2024, the Secretary amended the April 19, 2013, determination made pursuant to the FD&C Act, regarding the avian influenza A (H79N) virus, and determined pursuant to his authority under the Act that there is a significant potential for a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad and that involves biological agents, namely pandemic influenza A viruses and influenza A viruses with pandemic potential.","document_number":"2024-16247","html_url":"https://www.federalregister.gov/documents/2024/07/24/2024-16247/declaration-of-emergency-pursuant-to-the-federal-food-drug-and-cosmetic-act","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-07-24/pdf/2024-16247.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-16247.pdf?1721738728","publication_date":"2024-07-24","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Office of the Secretary"}],"excerpts":"is made: (1) a determination by the Secretary of Homeland Security that there is a domestic emergency, or a significant potential for a domestic emergency, involving a heightened risk of attack with a chemical, biological, radiological, or nuclear (“CBRN”) agent or agents; (2) the identification of a material threat by the Secretary of the Homeland Security pursuant to section 319F-2 of the Public Health Service (PHS) Act sufficient to affect national \n \n security or the health and security of United States citizens living abroad; (3) a determination"},{"title":"Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the issuance of Emergency Use Authorizations (EUAs) (the Authorizations) for certain medical devices related to Coronavirus Disease 2019 (COVID-19). FDA has issued the Authorizations listed in this document under the Federal Food, Drug, and Cosmetic Act (FD&C Act). These Authorizations contain, among other things, conditions on the emergency use of the authorized products. The Authorization follows the February 4, 2020, determination by the Secretary of Health and Human Services (HHS), as amended on March 15, 2023, that there is a public health emergency, or a significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad and that involves the virus that causes COVID-19, and the subsequent declarations on February 4, 2020, March 2, 2020, and March 24, 2020, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19, personal respiratory protective devices, and medical devices, including alternative products used as medical devices, respectively, subject to the terms of any authorization issued under the FD&C Act. These Authorizations, which include an explanation of the reasons for issuance, are listed in this document, and can be accessed on FDA's website from the links indicated.","document_number":"2024-18973","html_url":"https://www.federalregister.gov/documents/2024/08/23/2024-18973/authorization-of-emergency-use-of-certain-medical-devices-during-covid-19-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-08-23/pdf/2024-18973.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-18973.pdf?1724330733","publication_date":"2024-08-23","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"Services (HHS), as amended on March 15, 2023, that there is a public health emergency, or a significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad and that involves the virus that causes COVID-19, and the subsequent declarations on February 4, 2020, March 2, 2020, and March 24, 2020, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that"},{"title":"Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the issuance of Emergency Use Authorizations (EUAs) (the Authorizations) for certain medical devices related to Coronavirus Disease 2019 (COVID-19). FDA has issued the Authorizations listed in this document under the Federal Food, Drug, and Cosmetic Act (FD&C Act). These Authorizations contain, among other things, conditions on the emergency use of the authorized products. The Authorization follows the February 4, 2020, determination by the Secretary of Health and Human Services (HHS), as amended on March 15, 2023, that there is a public health emergency, or a significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad and that involves the virus that causes COVID-19, and the subsequent declarations on February 4, 2020, March 2, 2020, and March 24, 2020, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19, personal respiratory protective devices, and medical devices, including alternative products used as medical devices, respectively, subject to the terms of any authorization issued under the FD&C Act. These Authorizations, which include an explanation of the reasons for issuance, are listed in this document, and can be accessed on FDA's website from the links indicated.","document_number":"2024-16358","html_url":"https://www.federalregister.gov/documents/2024/07/25/2024-16358/authorization-of-emergency-use-of-certain-medical-devices-during-covid-19-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-07-25/pdf/2024-16358.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-16358.pdf?1721825130","publication_date":"2024-07-25","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"Services (HHS), as amended on March 15, 2023, that there is a public health emergency, or a significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad and that involves the virus that causes COVID-19, and the subsequent declarations on February 4, 2020, March 2, 2020, and March 24, 2020, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that"},{"title":"Distribution of Continued Dumping and Subsidy Offset to Affected Domestic Producers","type":"Notice","abstract":"Pursuant to the Continued Dumping and Subsidy Offset Act of 2000, this document is U.S. Customs and Border Protection's (CBP) notice of intent to distribute assessed antidumping and countervailing duties (known as the continued dumping and subsidy offset) for Fiscal Year 2026 in connection with countervailing duty orders, antidumping duty orders, and findings under the Antidumping Act of 1921. This document provides instructions for affected domestic producers, or anyone alleging eligibility to receive a distribution, to file certifications to claim a distribution in relation to the listed orders and findings, and to provide CBP with the necessary information to effect payment of a distribution by electronic funds transfer.","document_number":"2026-10350","html_url":"https://www.federalregister.gov/documents/2026/05/26/2026-10350/distribution-of-continued-dumping-and-subsidy-offset-to-affected-domestic-producers","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-05-26/pdf/2026-10350.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-10350.pdf?1779453908","publication_date":"2026-05-26","agencies":[{"raw_name":"DEPARTMENT OF HOMELAND SECURITY","name":"Homeland Security Department","id":227,"url":"https://www.federalregister.gov/agencies/homeland-security-department","json_url":"https://www.federalregister.gov/api/v1/agencies/227","parent_id":null,"slug":"homeland-security-department"},{"raw_name":"U.S. Customs and Border Protection","name":"U.S. Customs and Border Protection","id":501,"url":"https://www.federalregister.gov/agencies/u-s-customs-and-border-protection","json_url":"https://www.federalregister.gov/api/v1/agencies/501","parent_id":227,"slug":"u-s-customs-and-border-protection"}],"excerpts":"Division, Attn: CDSOA Team, must be notified, in writing, if a domestic producer believes one of the waiver criteria applies to it and if the domestic producer seeks payment of its CDSOA distribution by paper check. The domestic producer's written waiver request must include sufficient information to identify the domestic producer, the associated CDSOA certification(s), and the specific waiver provision within 31 CFR 208.4 upon which the domestic producer is relying. The burden is on the domestic producer to demonstrate that its circumstances satisfy the"},{"title":"Modernizing Security Requirements","type":"Proposed Rule","abstract":"The U.S. Nuclear Regulatory Commission (NRC) is proposing to revise its regulations to modernize security and fitness-for-duty requirements to enhance efficiency, consistent with Executive Order 14300, \"Ordering the Reform of the Nuclear Regulatory Commission.\" The proposed revisions are intended to reduce regulatory burden, where appropriate, while continuing to provide reasonable assurance that safety and security will be adequately maintained at NRC-licensed facilities.","document_number":"2026-12989","html_url":"https://www.federalregister.gov/documents/2026/06/26/2026-12989/modernizing-security-requirements","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-26/pdf/2026-12989.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-12989.pdf?1782391523","publication_date":"2026-06-26","agencies":[{"raw_name":"NUCLEAR REGULATORY COMMISSION","name":"Nuclear Regulatory Commission","id":383,"url":"https://www.federalregister.gov/agencies/nuclear-regulatory-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/383","parent_id":null,"slug":"nuclear-regulatory-commission"}],"excerpts":"Facility Security Clearance and Safeguarding of National Security Information and Restricted Data. \n The NRC is proposing to revise 10 CFR part 95, “Facility Security Clearance and Safeguarding of National Security Information and Restricted Data,” to remove requirements that are duplicative and to ensure alignment with 32 CFR part 117, “National Industrial Security Program Operating Manual (NISPOM).” These changes would provide references to the applicable provisions of 32 CFR part 117 for implementation of the National Industrial Security Program"},{"title":"Authorization of Emergency Use of an In Vitro Diagnostic Device in Response to an Outbreak of Mpox; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA) is announcing the issuance of an Emergency Use Authorization (EUA) (the Authorization) under the Federal Food, Drug, and Cosmetic Act (FD&C Act) in response to an outbreak of Mpox. FDA has issued an Authorization for an in vitro diagnostic device, Non-variola Orthopoxvirus Real-time PCR Primer and Probe Set as requested by the Centers for Disease Control and Prevention (CDC). The Authorization contains, among other things, conditions on the emergency use of the authorized product. The Authorization follows the August 9, 2022, determination by the Secretary of Health and Human Services (HHS) that there is a public health emergency, or a significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad, and that involves monkeypox virus. On the basis of such determination, the Secretary of HHS declared, on September 7, 2022, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of infection with the monkeypox virus, including in vitro diagnostics that detect and/or diagnose infection with non-variola Orthopoxvirus, pursuant to the FD&C Act, subject to terms of any authorization issued under that section. The Authorization, which includes an explanation of the reasons for issuance, and can be accessed on FDA's website from the link indicated in Section III. Authorization.","document_number":"2024-14719","html_url":"https://www.federalregister.gov/documents/2024/07/05/2024-14719/authorization-of-emergency-use-of-an-in-vitro-diagnostic-device-in-response-to-an-outbreak-of-mpox","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-07-05/pdf/2024-14719.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-14719.pdf?1720010723","publication_date":"2024-07-05","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"the authorization based on one of the following grounds: (1) a determination by the Secretary of Homeland Security that there is a domestic emergency, or a significant potential for a domestic emergency, involving a heightened risk of attack with a biological, chemical, radiological, or nuclear agent or agents; (2) a determination by the Secretary of Defense that there is a military emergency, or a significant potential for a military emergency, involving a heightened risk to U.S. military forces, including personnel operating under the authority"},{"title":"Hazardous Materials: Reducing Burdens on Domestic Companies Using Battery-Powered Equipment in Trades","type":"Proposed Rule","abstract":"This NPRM proposes to amend the Materials of Trade (MOTs) exceptions to allow for the transportation of increased quantities of lithium batteries. The current MOT exceptions unnecessarily limit the number and size of lithium batteries that can be safely transported by domestic construction, landscaping, mowing, tree service, food service, and entertainment companies in support of performing a trade.","document_number":"2025-12065","html_url":"https://www.federalregister.gov/documents/2025/07/01/2025-12065/hazardous-materials-reducing-burdens-on-domestic-companies-using-battery-powered-equipment-in-trades","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-01/pdf/2025-12065.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-12065.pdf?1751055311","publication_date":"2025-07-01","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Pipeline and Hazardous Materials Safety Administration","name":"Pipeline and Hazardous Materials Safety Administration","id":408,"url":"https://www.federalregister.gov/agencies/pipeline-and-hazardous-materials-safety-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/408","parent_id":492,"slug":"pipeline-and-hazardous-materials-safety-administration"}],"excerpts":"However, this proposed rule is not a “significant energy action” under E.O. 13211 (“Actions Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use”),\n 7 \n \n which requires Federal agencies to prepare a Statement of Energy Effects for any “significant energy action.” Because this proposed rule is not a significant action under E.O. 12866, it will not have a significant adverse effect on supply, distribution, or energy use; OIRA has therefore not designated this proposed rule as a significant energy action.\n \n \n \n 7 \n 66 FR"}]}